Sonablate's HIFU Technology To Treat Patients with Prostate Condition

Sonablate is pleased to present its most recent innovation At the Rajiv Gandhi Cancer Institute and Research Centre in Delhi. Sonablate HIFU (Extreme focus Centered Ultrasound) innovation. Patients with prostate conditions can now receive precise and focused ablative energy from a robotic device that is minimally invasive. The authorized distributor for the Sonablate HIFU Robotic Device in India is NovoMed Incorporation Pvt Ltd.

The key benefit of the Sonablate's advanced technology (HIFU) is the fact that it is a customizable procedure targeting only the affected prostate issue, thereby reducing risk of collateral damage to surrounding healthy tissues. Further, it is also a minimally invasive, radiation-free, bloodless ablation with much shorter recovery periods, as per pharmabiz. Speaking on the occasion, Dr Sudhir Rawal, medical director and chief of GenitoUro - oncology services, Rajiv Gandhi Cancer Institute and Research Centre, opined, “Our Institute has been using this machine since February, 2023 and till now it has been working smoothly. It is a user-friendly device which requires proper training prior to the onset of the programme. This procedure gives minimal discomfort and the least side effects to the patient with adequate treatment for the disease. Intraoperative and postoperative complications of radical prostatectomy (RALP) like pain, erectile dysfunction, urinary incontinence etc. are avoided. Also, the side effects of radiation like GI toxicity, hematuria etc. are avoided. The patient also has an option of surgical, or radiation treatment if there is recurrence.”